+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4



Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4



Journal of Biological Chemistry 279(44): 45685-45692



Microsomal triglyceride transfer protein (MTP) is involved in the transfer of triglycerides, cholesterol esters, and phospholipids to newly synthesized apolipoprotein (apo) B. It is therefore essential for lipoprotein synthesis and secretion in the liver and the small intestine. Although several recent experiments have revealed the transcriptional regulation of the MTP gene, little has been revealed to date about hepatocyte nuclear factor-4 (HNF-4)-dependent regulation. We here report that the human MTP gene promoter contains a pair of functional responsive elements for HNF-4 and HNF-1, the latter of which is another target gene of HNF-4. Chromatin immunoprecipitation assays provide evidence that endogenous HNF-4 and HNF-1 can bind these elements in chromatin. In Hep G2 cells overexpression of either a dominant negative form of HNF-4 or small interfering RNAs (siRNAs) against HNF-4 dramatically reduces the activities of both the wild type and the HNF-4 site mutant MTP promoter. This suggests that HNF-4 regulates MTP gene expression either directly or indirectly through elevated HNF-1 levels. When Hep G2 cells were cultured with chenodeoxycholic acid (CDCA), a ligand for the farnesoid X receptor (FXR), mRNA levels for MTP and apo B were reduced because of increased expression of the factor small heterodimer partner (SHP), which factor suppresses HNF-4 activities. Chenodeoxycholic acid, but not a synthetic FXR ligand, attenuated expression of HNF-4, bringing about a further suppression of MTP gene expression. Over time the intracellular MTP protein levels and apo B secretion in the culture medium significantly declined. These results indicate that two nuclear receptors, HNF-4 and FXR, are closely involved in MTP gene expression, and the results provide evidence for a novel interaction between bile acids and lipoprotein metabolism.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011803921

Download citation: RISBibTeXText

PMID: 15337761

DOI: 10.1074/jbc.m404255200


Related references

Hepatocyte nuclear factor 1 binding element within the promoter of microsomal triglyceride transfer protein (MTTP) gene is crucial for MTTP basal expression and insulin responsiveness. Journal of Molecular Endocrinology 41(4): 229-238, 2008

Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. Journal of Biological Chemistry 281(44): 33066-33077, 2006

Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. Journal of Biological Chemistry 277(32): 28795-28802, 2002

Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4. Journal of lipid research 46(2): 328-341, 2005

Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4alpha. Journal of Lipid Research 46(2): 328-341, 2005

Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression. Journal of Biological Chemistry 287(24): 20122-20131, 2012

Microsomal triglyceride transfer protein activity remains unchanged in rat livers under conditions of altered very-low-density lipoprotein secretion. Biochemical Journal 310: 11-14, 1995

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. Faseb Journal 16(2): 185-194, 2002

The role of hepatic nuclear factor 4-alpha in mediating the effects of dietary saturated fatty acids on the expression of the microsomal triglyceride transfer protein gene. Proceedings of the Nutrition Society 62(OCA-B): 78A, Autumn, 2003

Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein. Metabolism: Clinical and Experimental 58(9): 1306-1311, 2009

Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation. Biochemistry 42(5): 1283-1291, 2003

A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion. Journal of Biological Chemistry 275(11): 7515-7520, 2000

Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells. Journal of Nutrition 135(4): 702-706, 2005

Emerging low-density lipoprotein therapies: Microsomal triglyceride transfer protein inhibitors. Journal of Clinical Lipidology 7(3 Suppl): S16-S20, 2013

Inhibition of microsomal triglyceride transfer protein expression and atherogenic risk factor apolipoprotein B100 secretion by tanshinone IIA in HepG2 cells. PhytoTherapy Research 22(12): 1640-1645, 2008